Background/Aims: To date, several positron emission tomography/computed tomography (PET/CT) radiotracers including fluorine-18 fluorodeoxyglucose (18F-FDG), carbon-11 labeled choline (11C-choline), 18-F fluorocholine (18F-FCH) and carbon-11 acetate (11C-acetate) have already been assessed in the application of prostate cancer (PCa) diagnosis to some extent, the diagnostic efficiency of these radiotracers still remain controversial. As a result of this, we carried out this meta-analysis for the purpose of comparing the diagnostic accuracy among four PET/CT radiotracers. Methods: A systematical literature search for articles was performed until July 3, 2015. We implemented all analysis using the statistical software of STATA12 and quality assessment was performed using QUADAS-2. Results: A total of 56 studies containing 3,586 patients were included in this meta-analysis. Parameter estimates of the overall analysis are as follows: sensitivity, 0.80 (95% CI: 0.74-0.85); specificity, 0.84 (95% CI: 0.77-0.89) and area under roc curve-AUC of SROC, 0.89 (95% CI: 0.86-0.91), indicating a relatively high level of accuracy in diagnosis of PCa. When different radiotracers of PET/CT were compared, 18F-FCH-PET/CT was ranked as the most favorable with the highest value of AUC (AUC = 0.94; 95% CI: 0.92-0.96) whereas 18F-FDG was the least favorable (AUC = 0.73, 95% CI: 0.69-0.77). Conclusion: This study suggested that PET/CT imaging plays an invaluable role in the diagnosis of PCa and 18F-FCH-PET/CT was considered as a superior diagnostic tool over other radiotracers. More attention should be paid to the diagnostic efficiency of the four radiotracers particularly for PCa patients with different clinical stages.
Influence of Four Radiotracers in PET/

Statistical methods
Statistical heterogeneity was evaluated by the statistic of Q and I 2 . P < 0.01 and I 2 > 50% indicates significant study heterogeneity [25] , then the random-effects model would be performed to calculate the pooled estimates, otherwise a fixed-effect model would be carried out for the meta-analysis. The diagnostic accuracy of four PET/CT radiotracers was evaluated by several measures including the sensitivity, specificity, positive likelihood ratio-PLR, negative likelihood ratio-NLR, diagnostic odds ratio and AUC. Summary receiver operating characteristics (SROC) curves were generated to present parameter estimates using the method of inverse variance. Besides that, subgroup analyses by ethnicity and type of PET/CT were conducted to explore the potential source of heterogeneity. Publication bias of the included studies was assessed by Deeks' Funnel Plot and symmetry test which indicated significant publication bias if P value was less than 0.1. We performed all statistical analysis by STATA12.0 (StataCorp, College Station, Texas).
Results
Included studies
A total of 1,313 studies were identified during the stage of initial search, 326 of the articles were eliminated for duplicate data and 637 studies were judged as unavailable by screening their titles and abstracts. The rest of 385 studies were read for full-text review. Finally, 56 studies containing 3,586 patients were included according to the inclusion and exclusion criteria. The entire process of the literature search was presented in Fig. 1 .
Study populations and their characteristics were summarized in Table 1 . QUADAS-2 scores indicated that all of the admitted studies were reliable with scores ranging from 6 to 9 out of 10. The included studies were reported in different countries, of those, 42 studies were performed in Europe, 7 in Asia, and 7 in Australia. In total, there were 3,743 patients as the case group and 3,586 matched healthy people as the control group. All included studies were published between 2005 and 2015 (11C-choline: n = 31 , 18F-FCH: n = 15 [17, [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] , 11C-acetate: n = 5 [69] [70] [71] [72] [73] , 18F-FDG: n = 5 [74] [75] [76] [77] [78] ). 
Summary of the diagnostic performance
First of all, test of heterogeneity was performed to assess whether the included studies were homogeneous and then the pooled diagnostic statistics were evaluated. I 2 values for sensitivity and specificity was 90.24% (95% CI: 88.31-92.16%, P < 0.001) and 95.60% (95% CI: 94.91-96.28%, P < 0.001), respectively. A random-effects model was adopted to assess the pooled data due to the existence of significant heterogeneity among studies. As suggested by Table 2 
Subgroup analysis
Subgroup analysis by types of PET/CT was performed to assess whether there was significant heterogeneity among the four PET/CT radiotracers in respect of diagnostic accuracy. We implemented a random-effects model for 11C-PET/CT, 18F-FCH-PET/CT and 18F-FDG due to the presence of significant heterogeneity (I 2 > 50%, P < 0.001) (Fig. 2-5 ). Cell (Fig. 6) . Table 2 
Discussion
PET/CT has been developed as a new technology to improve the accuracy of clinical molecular imaging, especially for phymatology [7] . Moreover, the development of PET/CT radiotracers is critical to the early diagnosis of cancer which may enhance the chance of survival for cancer patients. Major radiotracers including 18F-FDG, 11C-choline, 18F-FCH and 11C-acetate enabled us to visualize tumor metabolisms and hence precisely assess the stage of cancer. As one of the first radiotracers, 18F-FDG is associated with low sensitivity and specificity especially in diagnosing well-differentiated PCa as its diagnostic accuracy is related to urinary excretion. Hence, 18F-FDG has limited performance on PCa diagnosis [10] . Other PET radiotracers, such as 18F-FCH, 11C-choline and 11C-acetate have been recommended and encouraging results were obtained [79] [80] [81] [82] [83] [84] . Although, a systematic review has investigated the application of 18F-FCH PET/CT in PCa diagnosis [85] , these recommendations remained unclear and the overall diagnostic performance remained vague. 
Cellular Physiology and Biochemistry
Therefore, the diagnostic accuracy of the four radiotracers in PET/ CT were compared and assessed in this meta-analysis in order to address the issue of inconsistency resulted from study heterogeneity.
Our study indicated that 11C-acetate was more accurate than 18F-FDG with respect to the diagnostic accuracy of PCa and this was consistent with those results from previous studies [81, 86] . The diagnostic superiority of 11C-acetate over 18F-FDG may be explained by several facts. Firstly, 18F-FDG was mainly excreted through kidneys, urinary bladder and urethra which may result in the obscure of the urinary bladder. On the contrary, 11C-carbon dioxide which is the primary metabolite of 11C-acetate rapidly exhales through the respiratory system and the remaining 11C-acetate filtered through kidney are almost negligible. Hence, the visualization of PCa tissues is not interfered with the elimination of 11C-acetate, especially for regional lymph node metastasis and local recurrence PCa. Indeed, 11C-acetate could contribute to prostate-specific citrate metabolism which may be beneficial to tumor detection for localized PCa [81] .
Both 18F-FCH and 11C-cholineare choline PET/CT and the result indicated that they were significantly better than 11C-acetate. Since choline is an important component in synthesizing phospholipids, the activity of choline has substantial influence on the activity of the enzyme choline kinase and PCa cell proliferation. Therefore, an elevated activity of choline and kinase could be detected in malignant cells [87] . Moreover, the promising results were also obtained in the preoperative staging of pelvic lymph nodes for PCa patients [84] . However, 11C-choline radiotracers have a relatively short half-life which could be overcome by 18F-FCH. Hence, 18F-FCH seems to be more accurate than 11C-choline in respect of PCa diagnosis [88, 89] .
Subgroup analysis by ethnicity revealed that Caucasian population (AUC = 0.90) had significantly higher diagnostic accuracy than Asian (AUC = 0.77). The significant diagnostic difference between the two ethnicities may be attributable to the fact that almost all of the Asian populations in our study were diagnosed by18-FDG whose diagnosis efficiency was relatively low.
Despite of the innovation and potential advantages in our meta-analysis, certain limitations still existed. First of all, the synthesized results were not applicable to other ethnicity since there were no African populations involved in our study. Secondly, subgroup analysis by radiotracers was not feasible due to insufficient data. Thirdly, some potential factors that affect the diagnostic accuracy of PCa were not assessed due to the clinical and biological complexity of PCa. For instance, the diagnostic accuracy is likely to be affected by different clinical stages of PCa, including locally recurrent, metastatic and loco regional lymph nodes PCa and this kind of information was not available. In addition, the absence of a thorough histopathological analysis for tumor tissues further reduces the credibility of the results.
For summary, our meta-analysis assessed four radiotracers employed in PET/CT for PCa detection. The results obtained from this study suggested that PET/CT imaging plays an irreplaceable role in PCa diagnosis. Among the four radiotracers, Choline PET/CT particularly 18F-FCH PET/CT were more favorable than others in respect of PCa diagnostic accuracy. Still, we strongly recommended that future studies which are applicable to all ethnicities and adjusted for potential confounding factors should be designed to confirm our conclusion.
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